BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1459833)

  • 1. Calcium blockers enhance cisplatin-induced nephrotoxicity in rats.
    Uozumi J; Ueda T; Yasumasu T; Koikawa Y; Kumazawa J
    Int Urol Nephrol; 1992; 24(5):549-53. PubMed ID: 1459833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
    Hanada K; Odaka K; Kudo A; Ogata H
    Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.
    Hammoud SH; Alkhansa S; Mahjoub N; Omar AG; El-Mas MM; Eid AA
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F572-F582. PubMed ID: 29767558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord.
    Omote K; Sonoda H; Kawamata M; Iwasaki H; Namiki A
    Anesthesiology; 1993 Oct; 79(4):746-52. PubMed ID: 8214754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of calcium channel blockers on cyclosporine A (Cs A) induced nephrotoxicity in rats.
    Zima T; Nĕmecek K; Hátle K; Bártová V; Stípek S
    Sb Lek; 1995; 96(1):15-21. PubMed ID: 8711361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
    Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
    Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of combination antitumor chemotherapy with calcium channel blockers and cis-diamminedichloroplatinum(II).
    Onoda JM; Nelson KK; Taylor JD; Honn KV
    Cancer Res; 1989 Jun; 49(11):2844-50. PubMed ID: 2720644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic effect of methylprednisolone against cisplatin-induced nephrotoxicity in rats.
    Koikawa Y; Uozumi J; Ueda T; Yasumasu T; Kumazawa J
    Toxicol Lett; 1993 Mar; 66(3):281-5. PubMed ID: 8475508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroprotective effect of calcium channel blockers against toxicity of lead exposure in mice.
    Zhang J; Cao H; Zhang Y; Zhang Y; Ma J; Wang J; Gao Y; Zhang X; Zhang F; Chu L
    Toxicol Lett; 2013 Apr; 218(3):273-80. PubMed ID: 23428833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and quantitative detection of cisplatin-induced nephrotoxicity by measurement of plasma PSP (phenolsulfonphthalein) half-life in rats.
    Uozumi J; Ueda T; Koikawa Y; Yasumasu T; Kumazawa J
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):901-4. PubMed ID: 8254999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of calcium load and the calcium channel blocker verapamil on gentamicin nephrotoxicity in rats.
    Ali BH; Al-Qarawi AA; Mousa HM
    Food Chem Toxicol; 2002 Dec; 40(12):1843-7. PubMed ID: 12419699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible mechanism of PNS protection against cisplatin-induced nephrotoxicity in rat models.
    Liu X; Huang Z; Zou X; Yang Y; Qiu Y; Wen Y
    Toxicol Mech Methods; 2015; 25(5):347-54. PubMed ID: 25598344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model.
    Sayed-Ahmed MM; Eissa MA; Kenawy SA; Mostafa N; Calvani M; Osman AM
    Chemotherapy; 2004 Oct; 50(4):162-70. PubMed ID: 15347908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.
    Jones MM; Basinger MA; Beaty JA; Holscher MA
    Cancer Chemother Pharmacol; 1991; 29(1):29-32. PubMed ID: 1742846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of local lignocaine-induced sensory block by calcium channel blockers in rats.
    Iwasaki H; Ohmori H; Omote K; Kawamata M; Sumita S; Yamauchi M; Namiki A
    Br J Anaesth; 1996 Aug; 77(2):243-7. PubMed ID: 8881634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone reduces the nephrotoxicity caused by cisplatin.
    Uozumi J; Koikawa Y; Ueda T
    J Pharmacobiodyn; 1992 Dec; 15(12):693-7. PubMed ID: 1296980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity in rats].
    Koikawa Y; Uozumi J; Yasumasu T; Ueda T; Kumazawa J
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1363-7. PubMed ID: 8346934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between blood pressure and plasma catecholamine concentration after administration of calcium antagonists to rats.
    Imai K; Higashidate S; Prados PR; Santa T; Adachi-Akahane S; Nagao T
    Biol Pharm Bull; 1994 Jul; 17(7):907-10. PubMed ID: 8000374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nicardipine, nifedipine, verapamil, and diltiazem on urine volume, sodium and potassium excretion and plasma aldosterone levels in the rat.
    Rosenkranz RP; McClelland DL; Roszkowski AP
    Proc West Pharmacol Soc; 1984; 27():67-72. PubMed ID: 6494200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.